HB 72 signed into law, improves access to healthcare, X-ray services
HENDERSON, Ky. (WEHT) – Officials say at the end of March, House Bill 72, sponsored by Owensboro Representative DJ Johnson, was signed into law. The measure expands access to healthcare and is intended to help avoid long waits and backlogs in X-ray services.
Legislators say the new law allows a limited X-ray machine operator to be employed to perform medical imaging at a facility where contrast studies, fluoroscopy, nuclear medicine or radiation therapy procedures are performed; however, they will only be permitted to perform limited diagnostic radiography.
AAUW to host tour honoring women of Daviess County
'Allowing limited X-ray operators to perform duties in facilities where other imaging equipment is being used will not only increase employment opportunities for these individuals but also help alleviate staffing shortages, improve operations, and expand access to care,' said Johnson.
According to the Kentucky House Majority Caucus, a limited X-ray machine operator means an individual who performs limited radiographic procedures that shall not include contrast studies, fluoroscopy, nuclear medicine or radiation therapy procedures.
Fourth arrest made in 5th Street shooting in Owensboro
'I am incredibly proud that House Bill 72 was signed into law. The measure gives medical practices more opportunities to hire limited X-ray operators,' Johnson added. 'This practical, commonsense measure seeks to eliminate barriers healthcare providers face in hiring qualified staff, offering them increased flexibility in how they staff their facilities.'
Officials say House Bill 72 will take effect on June 27.
Copyright 2025 Nexstar Media, Inc. All rights reserved. This material may not be published, broadcast, rewritten, or redistributed.
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
3 hours ago
- Yahoo
Asia-Pacific Transdermal Skin Patches Market Outlook 2025-2033: Trends for Pain Relief, Smoking Reduction & Cessation Aid, Overactive Bladder, Hormonal Therapy, and Other Applications
Innovations in microneedle and smart patch technologies are boosting efficacy and compliance, while government healthcare initiatives enhance access. Major players include Teva Pharmaceutical, 3M, and Johnson & Johnson. Growth is notably strong in China, India, and Japan due to demographic and health trends. Asia-Pacific Transdermal Skin Patches Market Dublin, June 05, 2025 (GLOBE NEWSWIRE) -- The "Asia-Pacific Transdermal Skin Patches Market Size and Share Analysis - Growth Trends and Forecast Report 2025-2033" has been added to Asia-Pacific Transdermal Skin Patches Market is expected to reach US$ 3.96 billion by 2033 from US$ 2.76 billion in 2024, with a CAGR of 4.10% from 2025 to 2033. Increasing prevalence of chronic diseases, aging population, requirement for pain-free drug delivery, technological innovation, growth in healthcare infrastructure, and rising awareness of self-administered therapies that ensure convenience and improved patient compliance are the key drivers of the transdermal skin patches market in Asia-Pacific. Several significant factors are behind the consistent rise of the transdermal skin patch market in Asia-Pacific. The increasing prevalence of chronic conditions such as diabetes, hypertension, and cardiovascular disease is a key driver, since it increases the need for safe, non-invasive drug delivery systems. Increased demand for user-friendly and convenient pharmaceutical solutions is also being driven by the ageing population in the region, most notably in countries such as China and Japan. Efficiency in drug delivery and compliance among patients are being enhanced by advances in technology in the form of smart patches and microneedle technology. In addition, the application of transdermal therapies in the region is being encouraged and access enhanced by government healthcare initiatives as well as increases in healthcare infrastructure. Growth Drivers for the Asia-Pacific Transdermal Skin Patches MarketRising prevalence of respiratory disease The Asian Pacific market for transdermal skin patches is growing largely because of the rising prevalence of chronic diseases. Owing to sedentary lifestyles, environmental influences, and aging populations, chronic conditions such as diabetes, cardiovascular diseases, COPD, and cancer are on the rise. The incidence of chronic obstructive pulmonary disease (COPD) in Indian non-smokers, for instance, ranged from 1.6% to 26.6%, a meta-analysis study published in the Reviews on Environmental Health journal in November 2023 revealed. Also, India detects over 1.39 million new cancer cases every year, the Kidwai Memorial Institute of Oncology says. Long-term medication is often required for most diseases, and transdermal patches offer a steady, non-invasive, and effective route of drug delivery that enhances patient compliance. Demand for effective and convenient treatment options, like transdermal patches, is expected to grow tremendously across the region as the incidence of chronic diseases rises. Technological Advancements The Asia-Pacific market for transdermal skin patches is growing with a swift pace due to technology advancements that raise patient comfort, therapeutic efficacy, and medication administration effectiveness. Transdermally treatable disorders have widened as a result of innovations such as microneedle patches, sensor-embedded smart patches, and better adhesives. These technologies enhance patient compliance, especially among the elderly and the chronically ill, through the delivery of controlled, sustained, and painless medication. Teikoku Seiyaku Co. Ltd. and Kowa Company Ltd.'s April 2023 marketing in Japan of ALLYDONE Patches 27.5 mg and 55 mg for the treatment of dementia caused by Alzheimer's disease is a good case in point. This launch highlights how innovative patch technologies can be employed to treat neurologic diseases. These technological innovations are expected to greatly boost the adoption of transdermal patches across the Asia-Pacific market as research and development proceed. Ageing Population The aging population of the Asia-Pacific region is one of the key drivers of the market for transdermal skin patches. The demand for non-invasive, easy-to-use medicine delivery methods is increasing as the elderly population grows, especially in countries such as China and Japan. China's National Bureau of Statistics announced in January 2022 that the nation's population would be around 1.412 billion in 2021 and is likely to increase to 1.43 billion by the year 2026. Due to their ease of use, sustained drug delivery, and minor side effects, transdermal patches are a preferred option for this aging group, which is often required to take long-term medication for ongoing diseases. The demand for transdermal patches in the region is being fueled by the ability to administer medicine oneself without constant hospital visits, which fits the demands of an aging population. The demand for these advanced distribution systems is expected to evolve further as the number of elderly individuals increases. Challenges in the Asia-Pacific Transdermal Skin Patches MarketLimited Drug Permeability One major obstacle facing the Asia-Pacific transdermal skin patch business is limited medication permeability. The kinds of pharmaceuticals that can be administered via patches are limited by the ineffectiveness of certain drugs un penetrating the epidermal barrier. This restriction lessens the transdermal patches' adaptability and keeps them from being applied to a wider variety of conditions. Skin penetration technologies are being improved by researchers, but this problem will prevent the market from expanding until these developments are widely adopted. Skin Irritation and Sensitivity Significant obstacles in the Asia-Pacific transdermal skin patch industry are skin sensitivity and irritation. Patients may stop wearing the patches regularly if they experience skin problems including rashes, redness, or allergic reactions after using them for an extended period of time. This may limit the market's potential and lower patient compliance. Manufacturers are working to address this by creating hypoallergenic, skin-friendly materials and advancing patch adhesive methods to reduce irritation and improve user comfort, but these issues continue to exist. Key Attributes Report Attribute Details No. of Pages 200 Forecast Period 2024-2033 Estimated Market Value (USD) in 2024 $2.76 Billion Forecasted Market Value (USD) by 2033 $3.96 Billion Compound Annual Growth Rate 4.1% Regions Covered Asia-Pacific Key Topics Covered1. Introduction2. Research & Methodology3. Executive Summary4. Market Dynamics4.1 Growth Drivers4.2 Challenges5. Asia-Pacific Transdermal Skin Patches Market5.1 Historical Market Trends5.2 Market Forecast6. Asia-Pacific Transdermal Skin Patches Market Share Analysis6.1 By Type6.2 By Application6.3 By Distribution Channel6.4 By Countries7. Type7.1 Matrix7.2 Reservoir7.3 Drug-in-Adhesive7.4 Other Types8. Application8.1 Pain Relief8.2 Smoking Reduction and Cessation Aid8.3 Overactive Bladder8.4 Hormonal Therapy8.5 Others9. Distribution Channel9.1 Hospital Pharmacies9.2 Retail Pharmacies9.3 Online Pharmacies10. Countries10.1 China10.2 Japan10.3 India10.4 South Korea10.5 Thailand10.6 Malaysia10.7 Indonesia10.8 Australia10.9 New Zealand10.10 Rest of Asia-Pacific11. Porter's Five Forces Analysis11.1 Bargaining Power of Buyers11.2 Bargaining Power of Suppliers11.3 Degree of Rivalry11.4 Threat of New Entrants11.5 Threat of Substitutes12. SWOT Analysis12.1 Strength12.2 Weakness12.3 Opportunity12.4 Threat13. Key Players Analysis13.1 Teva Pharmaceutical Industries Ltd.13.2 3M Company13.3 Nitto Denko Corporation13.4 Johnson & Johnson13.5 Luye Pharma Group13.6 Bayer AG13.7 Novartis AG13.8 Beiersdorf AG13.9 Viatris Inc.13.10 Abbott Laboratories For more information about this report visit About is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends. Attachment Asia-Pacific Transdermal Skin Patches Market CONTACT: CONTACT: Laura Wood,Senior Press Manager press@ For E.S.T Office Hours Call 1-917-300-0470 For U.S./ CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900
Yahoo
12 hours ago
- Yahoo
Owensboro's Big Daddy's BBQ sauce hits Kroger shelves
OWENSBORO, Ky. (WEHT) — One of Owensboro's own has a barbeque sauce hitting shelves at Kroger. Joshua Taylor created Big Daddy's BBQ sauce that is now available in 50 of this, after recovering from a major health battle. Big Daddy's BBQ sauce has won several awards and landed the opportunity through a Kroger food show in Louisville; Behind the bottle is a comeback story that may be as powerful as the flavor. The accomplishment comes after a life-threatening fight for Taylor that lasted several years. 'I've been disabled since 2008. I needed a heart transplant. I was at home [and] started watching BBQ Pitmasters on tv. Figured, I better just try it,' says Taylor entered his first competition in 2011, and he and his wife at one point opened a physical location for takeout downtown. In 2018, the very thing that had unexpectedly led him to his passion took a turn for the worse. 'I got put in the hospital. The right side of my heart started feeling really, really bad. I ended up with a device called a Left Ventricular Assisted Device (LVAD). It left me in a coma. I was in the hospital for 188 days,' says Taylor. With his wife by his side, Taylor underwent a successful heart and kidney transplant two years later. He had to relearn how to do basic things again like walk, but that didn't stop people from wondering how they could get their hands on his barbeque again. He says getting his sauce on shelves helps him continue to serve the people of Owensboro. 'The fact that I can think that somebody is going to top me, it really fuels my fire. [I get] the same thing when it comes to the barbecue sauce,' says Taylor. The pair spent months trading samples back and forth with the manufacturer until it was right. 'We were just searching. We were like a dog sniffing for like a scent. My wife found [the sauce on shelves]…so happy and we were taking pictures. We were just like doing these poses stuff,' says Taylor.'It's so exciting that we still don't know all the all the stores that they're in in Kentucky, but just being able to see our product on the shelf is unbelievable. Even if life isn't going your way, don't give up. Keep the dream alive,' says Jill Taylor, his wife. People in Owensboro can find Taylor's sauce at the Frederica Street and Parrish Avenue Kroger locations. For the Taylors, every bottle represents more than just a labor of love, but a second chance at life. Copyright 2025 Nexstar Media, Inc. All rights reserved. This material may not be published, broadcast, rewritten, or redistributed.
Yahoo
17 hours ago
- Yahoo
Arkansas legislative committee reviews, advances water quality standards
DEQ Director Bailey Taylor (left) and the division's chief legal counsel, Kesia Morrison, address the Joint Public Health Committee on June 4, 2025. (Ainsley Platt/Arkansas Advocate) The Joint Public Health, Welfare and Labor Committee on Wednesday reviewed amendments to Arkansas' surface water quality standards rule, which is part of the state's enforcement of the federal Clean Water Act. As part of the Clean Water Act, the state is required to review — and if necessary, revise — the standards every three years. The rule, currently called Rule 2, was pulled from last month's committee agenda to give lawmakers more time to review the changes, which include the addition of five new health-based water quality standards for benzene, methylbenzene, xylene, toluene and phenol. The rule also amends existing criteria for ammonia and cadmium, which haven't been updated in decades, to bring them in line with revisions made by the Environmental Protection Agency within the last 15 years. Rule 2 standards apply to surface waters — such as rivers, creeks, lakes and wetlands — not to drinking water, which is governed by a separate federal law, the Safe Drinking Water Act. While the Division of Environmental Quality oversees Arkansas' enforcement of the CWA, the Arkansas Department of Health enforces the SDWA in the state. 'It's not a blanket effluent limit,' DEQ Director Bailey Taylor told committee members. The standards are for the 'ambient' water quality, and permit limits for facilities like wastewater treatment plants and industrial plants that discharge waste into surface waters are backcalculated from the standards, she said. Under the revised rule, the 'primary contact season,' the period during which people are most likely to be recreating in the water by swimming, fishing or boating, would be extended by two months so it would now fall from April to October. Pressed by Greenwood Republican Rep. Lee Johnson for an explanation for the change, Taylor said standards during the primary contact season are tighter for some measures than outside of it to account for greater human contact with the water. Taylor singled out bacteria standards as one example. She said the change was made to account for water recreation that's been happening in April and October. Johnson said it was 'interesting' that the division was moving to make the change now, and asked if DEQ believed Arkansans were swimming more in 2025 than they were in 2020 or in the 1980s. 'I just wonder why we're deciding now to change the recreational season when it's been in effect for a long time,' Johnson said. Taylor said the division was trying to account for recreation that was happening outside of the traditional May to September season. Johnson countered by asking if DEQ had collected any data showing that more people were engaging in water recreation during the extended months. Taylor said the decision was based on 'anecdotal stakeholder engagement.' The rule will next be considered by the Arkansas Legislative Council's Administrative Rules Subcommittee. SUPPORT: YOU MAKE OUR WORK POSSIBLE
